Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients

Biotechnology and Bioengineering

Volumn 100, Issue 6, 2008, Pages 1205-1213

  Mosadegh, Bobak ^a   Saadi, Wajeeh ^a   Wang, Shur Jen ^a   Jeon, Noo Li ^a  

^a University of California at Irvine   (United States)

Author keywords

Autocrine signaling; Breast cancer; Chemotaxis; CXCL12; EGF; Microfluidics

Indexed keywords

AUTOCRINE SIGNALING; BREAST CANCER; BREAST CANCER CELLS; BREAST CANCERS; CANCER CELLS; CANCER METASTASIS; CELL MIGRATION; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CHEMOTAXIS; CXCL12; EGF; EPIDERMAL GROWTH FACTOR; EXOGENOUS FACTORS; GROWTH FACTORS; MICRO-FLUIDIC; MICROFLUIDICS; PARACRINE;

BIOACTIVITY; BIOASSAY; BIOCHEMISTRY; CELL GROWTH; CYTOLOGY; GRADIENT METHODS; NANOFLUIDICS; PATHOLOGY; PEPTIDES;

CELLS;

EPIDERMAL GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CELL MIGRATION; CHEMOTAXIS; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MICROFLUIDICS; PARACRINE SIGNALING;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL12; CHEMOTAXIS; CULTURE MEDIA, CONDITIONED; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; RECEPTORS, CXCR4; RESEARCH DESIGN; SIGNAL TRANSDUCTION;

EID: 48649088413     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21851     Document Type: Article

References (32)

1. Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X, Lu G, Timm M, Kumar A, Côté D, Veilleux I, Hedin KE, Roodman GD, Witzig TE, Kung AL, Hideshima T, Anderson KC, Lin CP, Ghobrial IM. 2007. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109:2708-2717.
2. Bachelder RE, Wendt MA, Mercurio AM. 2002. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CX CR4. Cancer Res 62: 7203-7206.
3. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev Immunol 15:675-705.
4. Balkwill F. 2004. Cancer and the chemokine network. Nat Rev Cancer 4: 540-550.
5. Carpio P, Mur C, Rosel P, Navarro M. 1999. Constitutive and regulated secretion of epidermal growth factor and transforming growth factor B in MDA-MB-231 breast cancer cell line in 11-day cultures. Cell Signal 11:753-757.
6. Chung BG, Flanagan LA, Rhee SW, Schwartz PH, Lee AP, Monuki ES, Jeon NL. 2005. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip 5:401-406.
7. Condeelis JS, Wyckoff JB, Bailly M, Pestell R, Lawrence D, Backer J, Segall JE. 2001. Lamellipodia in invasion. Semin Cancer Biol 11:119-128.
8. Dertinger SKW, Chiu DT, Jeon NL, Whitesides GM. 2001. Generation of gradients having complex shapes using microfluidic networks. Anal Chem 73:1240-1246.
9. Ebnet K, Vestweber D. 1999. Molecular mechanisms that control leukocyte extravasation: The selectins and the chemokines. Histochem Cell Biol 112:1-23.
10. Foxman EF, Campbell JJ, Butcher EC. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139:1349-1360.
11. Foxman EF, Kunkel EJ, Butcher EC. 1999. Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol 147:577-588.
12. Heit B, Tavener S, Raharjo E, Kubes P. 2002. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol 159:91-102.
13. Hwang JH, Chung HK, Kim DW, Hwang ES, Suh JM, Kim H, You KH, Kwon OY, Ro HK, Jo DY, Shong M. 2003. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 88:408-416.
14. Jeon NL, Dertinger SKW, Chiu DT, Whitesides GM. 2000. Generation of solution and surface gradients using microfluidic systems. Langmuir 16:8311-8316.
15. Jeon NL, Baskaran H, Dertinger SKW, Whitesides GM, Van De Water L, Toner M. 2002. Neutrophil chemotaxis in linear and complex gradients of Il-8 formed in a microfabricated device. Nat Biotechnol 20:826-830.
16. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, et al. 2000. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: A possible role for tumor progression. Clin Cancer Res 6: 3530-3535.
17. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf Df, Zhang J, Ratajczak J, Ratajczak MZ. 2004. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Hist 35:233-245.
18. Lee BC, Lee TH, Avraham S, Avraham HK. 2004. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2:327-338.
19. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, leon NL. 2004. Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem Biophys Res Commun 319:576-581.
20. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, Jeon NL. 2005. Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann Biomed Eng 33:475-482.
21. Moore MA. 2001. The role of chemoattraction in cancer metastases. Bioessays 23:674-676.
22. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
23. Phillips RJ, Burdick MD, Lutz M, Belperio IA, Keane MP, Strieter RM. 2003. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167:1676-1686.
24. Porcile C, Bajetto A, Barbieri F, Barbero S, Bonavia R, Biglieri M, Pirani P, Florio T, Schettini G. 2005. Stromal cell-derived factor-la (SDF-1a/ CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 308:241-253.
25. Prasad A, Fernandis AZ, Rao Y, Ganju RK. 2004. Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem 279:9115-9124.
26. Rollins BJ. 1997. Chemokines. Blood 90:909-928.
27. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. 2001. Epithelial cancer cell migration: A role for chemokine receptors? Cancer Res 61: 4961-4965.
28. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR. 2002. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62:5930-5938.
29. Wang S-J, Saadi W, Lin F, Nguyen CM-C, Jeon NL. 2004. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 300:180-189.
30. Ward SG, Bacon K, Westwick J. 1998. Chemokines and T lymphocytes: More than an attraction. Immunity 9:1-11.
31. Whitesides GM, Ostuni E, Takayama S, Jiang X, Ingber DE. 2001. Soft lithography in biology and biochemistry. Annu Rev Biomed Eng 3:335-373.
32. Zlotnik A. 2004. Chemokines in neoplastic progression. Semin Cancer Biol 14:181-185.